We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Dragon
Careers
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.
VISCHER advised Forty51 Ventures, a Biotech venture capital firm, on its first fund, Forty51 Ventures Fund I SCSp, FIAR, which raised USD 43 million in a first closing and is domiciled in Luxemburg (the "Fund").
The management acquired 60% of the share capital of Roventa-Henex SA, a leading manufacturer of quality Swiss Made Private Label watches founded in 1959. Munich-based Findos Investor GmbH retains the remaining 40% of the share capital.
QoQa Brew SA, a subsidiary of QoQa Services SA, financed its craft brewery through a security token offering.
Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for the treatment of metabolic obstructive sleep apnea, closes a Seed Financing Round led by Forty51 Ventures.
ImmunOs Therapeutics AG has agreed to a CHF 74 million Series B financing led by incoming co-lead investors Samsara Biocapital, Lightspeed Venture Partners and Gimv, corner-stoned by GL Capital, Mission BioCapital, Peak 6 Strategic Capital and Fiscus Financial
Engimmune Therapeutics AG, a biotech company based in Basel developing novel T-cell receptor (TCR)-based therapeutics, closed a CHF 15.5m seed financing round.
Cimeio Therapeutics announced its launch including a USD 50m Series A commitment made by Versant Ventures.
Funds advised by Gilde Buy Out Partners, a leading European private equity investor, completed the investment in MBK Fincom ("MBK" or the "Company"), alongside the founders and management which are reinvesting in the business....
NEMIS Technologies AG closed a CHF 7.75m Series A financing round with the participation of both institutional and private investors.
Displaying results 21 to 30 out of 154
